LMHPCO - Home LMHPCO Home
Member Login
spacer
Member Center Hospice Professionals LMHPCO Events Message Board Forum Patients, Family & Caregivers Find a Hospice About LMHPCO Donate Search LMHPCO

spacer

more information:

Teleconferences

Conferences

Publications

Appropriateness Criteria

C.E.U.s Online

Email a link to this pageSend Link Email a link to this pagePrintable View

HIV DISEASE

HOSPICE HIV DISEASE
[1/29/1998]

LMRP DESCRIPTION:
Medicare coverage of hospice care depends upon a physician's certification of an individual's prognosis of a life expectancy of six months or less, if the terminal illness runs its normal course. Recognizing that determination of life expectancy during the course of a terminal illness is difficult, this intermediary has established medical criteria for determining prognosis for non-cancer diagnoses. These criteria form a reasonable approach to the determination of life expectancy based on available research, and may be revised, as more research is available. Coverage of hospice care for patients not meeting the criteria in this policy may be denied. However, some patients may not meet the criteria, yet still be appropriate for hospice care, because of other comorbidities or rapid decline. Coverage for these patients may be approved on an individual consideration basis.

INDICATIONS AND LIMITATIONS OF COVERAGE AND/OR MEDICAL NECESSITY:
Patients will be considered to be in the terminal stage of their illness (life expectancy of six months or less) if they meet the following criteria:

HIV Disease (1 and 2 must be present; factors from 3 will add supporting documentation)

1. CD4+ Count <25 cells/mcL or persistent viral load >100,000 copies/ml, plus one of the following:

a. CNS lymphoma
b. Untreated, or not responsive to treatment, wasting (loss of 33% lean body mass)
c. Mycobacterium avium complex (MAC) bacteremia, untreated, unresponsive to treatment, or treatment refused
d. Progressive multifocal leukoencephalopathy
e. Systemic lymphoma, with advanced HIV disease and partial response to chemotherapy
f. Visceral Kaposi's sarcoma unresponsive to therapy
g. Renal failure in the absence of dialysis
h. Cryptosporidium infection
i. Toxoplasmosis, unresponsive to therapy

2. Decreased performance status, as measured by the Karnofsky Performance Status (KPS) scale of less than or equal to 50.

3. Documentation of the following factors will support eligibility for hospice care:

a. Chronic persistent diarrhea for one year
b. Persistent serum albumin <2.5
c. Concomitant, active substance abuse
d. Age >50 years
e. Absence of antiretroviral, chemotherapeutic and prophylactic drug therapy related specifically to HIV disease
f. Advanced AIDS dementia complex
g. Toxoplasmosis
h. Congestive heart failure, symptomatic at rest

spacer
spacer
Contact LMHPCO Site Map Privacy Policy Terms of Use
National Hospice and Palliaive Care Organization - nhpco.org Hospice Foundation of America - hospicefoundation.org Palliative Care Institute
new orleans website design by wyatt lane
© LMHPCO - All rights reserved.